Medicinal Chemistry

Medicinal Chemistry, Drug Discovery and Development Services

Dalton Medicial Chemistry was built on 30 years of strength and excellence at Dalton Pharma Services. Dalton Medicinal Chemistry is a highly focused team of committed, knowledgeable medicinal chemists with expertise in small molecule drug discovery and development.

Dalton Medicinal Chemistry augments your in-house expertise and capabilities, serving as an extension of your own R&D group and as a responsive and reliable partner. We work closely with our partners to design and synthesize compounds for their targets and assays, leading ultimately to the identification of development candidates.

Our track record of identifying novel chemical entities for your Discovery/Development pipelines has been demonstrated todate through three publicly announced partnerships with Biotech (BioRelix & Bikam) and Pharma (Boehringer Ingelheim).

Dalton Medicinal Chemistry Focus

  • Quality and creativity
  • Commitment to achieving our customer’s goals
  • Timely, clear, detailed communication
  • Sensitivity to timelines
  • Adaptable to accommodate changing priorities

Dalton Medicinal Chemistry Expertise

  • Structure- and ligand-based analog design
  • Synthetic organic chemistry of all major chemotypes; focused library synthesis
  • Rapid, efficient execution of iterative design, synthesis and SAR elucidation
  • Experience in Drug Discovery of major target classes
  • Problem solving – synthetic Discovery, SAR analysis, ADMET issues

Dalton Medicinal Chemistry offers significant experience in Fragment-to-Lead, Hit-to-Lead, and Lead Optimization capabilities in advancing compounds to development against a wide variety of target types and therapeutic areas.

Selected Areas of Previous Experience

  • Antibacterials
  • Antivirals
  • Diabetes/obesity
  • Cancer/oncology
  • Neuropathic pain
  • Inflammation
  • Multiple Sclerosis
  • Alzheimer’s
  • Cardiovascular agents
  • Anti-aging

Contacts

Judd Berman
Cofounder
Dalton Medicinal Chemistry
416-661-2102 x331
jberman@dalton.com

Peter Pekos
Founder and President
Dalton Pharma Services
416-661-2102
ppekos@dalton.com